Compound Summary
Valpromide
Compound Information
Valpromide
Compound Name: | Valpromide |
Compound CID: | 71113 |
Synonyms: | Valpromide 2-PROPYLPENTANAMIDE 2430-27-5 Depamide Dipropylacetamide More... |
Iupac Name: | 2-propylpentanamide |
InChI: | InChI=1S/C8H17NO/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H2,9,10) |
InChIKey: | OMOMUFTZPTXCHP-UHFFFAOYSA-N |
Canonical Smiles: | CCCC(CCC)C(=O)N |
Isomeric Smiles: | CCCC(CCC)C(=O)N |
Molecular Weight: | 143.23 |
Molecular Formula: | C8H17NO |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
Valpromide
Molecular Weight: | 143.23 |
Molecular Formula: | C8H17NO |
Hydrogen Bond Donor Count: | 1 |
Hydrogen Bond Acceptor Count: | 1 |
Rotatable Bond Count: | 5 |
Heavy Atom Count: | 10 |
Complexity: | 95.4 |
Synonyms
Valpromide
| Valpromide | Valpromide |
|---|---|
Valpromide |
2-PROPYLPENTANAMIDE |
2430-27-5 |
Depamide |
Dipropylacetamide |
2,2-Di-n-propylacetamide |
Valpramide |
Pentanamide, 2-propyl- |
2-Propylpentamide |
2-Propylvaleramide |
2-Ethylvaleramide |
Propyl-2 valeramide |
Depamid |
Valeramide, 2-propyl- |
Valpromide INN |
UNII-RUA6CWU76G |
di-n-propylacetamide |
MFCD00051534 |
RUA6CWU76G |
CHEBI:74562 |
Valpromide (INN) |
NCGC00182080-02 |
alpha-Propylvaleramide |
Valpromida |
Valpromidum |
Valpromidum INN-Latin |
Valpromida INN-Spanish |
EINECS 219-394-2 |
BRN 1750444 |
Depamide (TN) |
2-propyl-pentanamide |
di-n-propyl acetamide |
Heptane-4-carboxamide |
1nu3 |
3g0i |
.alpha.-Propylvaleramide |
DSSTox_CID_3734 |
DSSTox_RID_77172 |
DSSTox_GSID_23734 |
SCHEMBL35392 |
CHEMBL93836 |
ZINC2238 |
Valpromide, >=97% (NMR) |
DTXSID1023734 |
HMS3886C09 |
HY-B2117 |
Tox21_113134 |
s4991 |
SBB015062 |
AKOS005068257 |
CCG-266167 |
CS-8176 |
DB04165 |
MCULE-7316825141 |
NCGC00182080-03 |
NCGC00182080-04 |
AS-58130 |
ST075166 |
SY096545 |
CAS-2430-27-5 |
FT-0609288 |
V0939 |
A16980 |
D02766 |
430D275 |
A817204 |
Q847560 |
SR-01000944932 |
SR-01000944932-1 |
W-107334 |
Experimental Data
Valpromide
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 6.000000000000000 | mM | 16.200000000000000 | 20.400000000000000 | 21.000000000000000 | 23.300000000000000 | 30.600000000000000 | 35.000000000000000 | S | N2 | 18248662 | Active |
Experimental Data Visualization
Valpromide
Statistics Data
Valpromide
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 21.000000000000000 | 35.000000000000000 | 1 | 1 |
Statistics Data Visualization
Valpromide
